To Get Personalised contents and be able to add items to your favourites, please Sign In or Sign Up          
 

Roche buys US biotech firm InterMune for £5bn


News » Sports
Nigeria

IMAGE: Roche »

August.26.2014

Intermune, which is based in Brisbane, California, makes a medicine for idiopathic pulmonary fibrosis, a deadly disease which scars the lungs.

The deal is the latest in a string of mergers in the drugs sector.

It is also the largest by Roche since 2009 when it bought the remainder of Genentech for about $47bn.

Pharmaceutical mergers

Roche will pay $78 per share in InterMune, which is a premium of 38% on top of the value of the shares at the end of last week.

Recent deals in the drug sector include US drug firm AbbVie's purchase of the UK pharmaceutical company Shire for £32bn.

UK High Street chemist Alliance Boots was bought up by US pharmacy giant Walgreens in an agreement earlier this month.

In May, pharmaceutical company Pfizer dropped a bid for UK company AstraZeneca.

Article Credit: BBC

Updated 4 Years ago
 

Find Us On Facebook

Tags:     Intermune     Brisbane     Roche     UK

RELATED